(Q64375474)
Statements
A Phase 1, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of TX-12-004-HR in Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy (VVA) (English)
0 references
July 2013
0 references
September 2013
0 references
50
0 references
40 year
0 references
75 year
0 references